Literature DB >> 23821048

Semax corrects brain dysfunction caused by prenatal introduction of valproic acid.

A V Malyshev1, E V Razumkina, V A Dubynin, N F Myasoedov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23821048     DOI： 10.1134/S0012496613030046

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  13 in total

1.  Neuronal plasticity and survival in mood disorders.

Authors:  R S Duman; J Malberg; S Nakagawa; C D'Sa
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

2.  The effect of semax on animal pain sensitivity in various experimental models.

Authors:  D M Ivanova; N G Levitskaya; L A Andreeva; L Yu Alfeeva; A A Kamenskii; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2003 Jan-Feb

3.  The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system.

Authors:  N G Levitskaya; E A Sebentsova; L A Andreeva; L Yu Alfeeva; A A Kamenskii; N F Myasoedov
Journal:  Neurosci Behav Physiol       Date:  2004-05

4.  Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism.

Authors:  Tomasz Schneider; Joanna Turczak; Ryszard Przewłocki
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

5.  Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

Authors:  Oleg V Dolotov; Ekaterina A Karpenko; Lyudmila S Inozemtseva; Tamara S Seredenina; Natalia G Levitskaya; Joanna Rozyczka; Elena V Dubynina; Ekaterina V Novosadova; Lyudmila A Andreeva; Lyudmila Yu Alfeeva; Andrey A Kamensky; Igor A Grivennikov; Nikolay F Myasoedov; Jürgen Engele
Journal:  Brain Res       Date:  2006-09-22       Impact factor: 3.252

6.  Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Authors:  Kirill O Eremin; Vladimir S Kudrin; Pirjo Saransaari; Simo S Oja; Igor A Grivennikov; Nikolay F Myasoedov; Kirill S Rayevsky
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

7.  [Changes in beta-casomorphine-7 effect on behavior of albino rat pups in postnatal development].

Authors:  V A Dubynin; Iu A Ivleva; I V Malinovskaia; A A Kamenskiĭ; L A Andreeva; L Iu Alfeeva; N F Miasoedov
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  2001 May-Jun       Impact factor: 0.437

8.  [Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats].

Authors:  D A Vilenskiĭ; N G Levitskaia; L A Andreeva; L Iu Alfeeva; A A Kamenskiĭ; N F Miasoedov
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2007-06

9.  Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.

Authors:  Tomasz Schneider; Ryszard Przewłocki
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

10.  Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996
View more
  1 in total

1.  Beneficial effects of xenon inhalation on behavioral changes in a valproic acid-induced model of autism in rats.

Authors:  A P Dobrovolsky; V R Gedzun; V I Bogin; D Ma; T E Ichim; Iu A Sukhanova; A V Malyshev; V A Dubynin
Journal:  J Transl Med       Date:  2019-12-03       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.